Annual Current Ratio
5.07
-5.72-53.01%
December 31, 2023
Summary
- As of March 10, 2025, GLUE annual current ratio is 5.07, with the most recent change of -5.72 (-53.01%) on December 31, 2023.
- During the last 3 years, GLUE annual current ratio has risen by +3.58 (+240.27%).
- GLUE annual current ratio is now -75.81% below its all-time high of 20.96, reached on December 31, 2021.
Performance
GLUE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
6.03
-0.53-8.08%
September 30, 2024
Summary
- As of March 10, 2025, GLUE quarterly current ratio is 6.03, with the most recent change of -0.53 (-8.08%) on September 30, 2024.
- Over the past year, GLUE quarterly current ratio has stayed the same.
- GLUE quarterly current ratio is now -81.84% below its all-time high of 33.20, reached on June 30, 2021.
Performance
GLUE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
GLUE Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.0% | 0.0% |
| 3 y3 years | +240.3% | 0.0% |
| 5 y5 years | +123.3% | 0.0% |
GLUE Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.8% | at low | -76.5% | +25.1% |
| 5 y | 5-year | -75.8% | +240.3% | -81.8% | +304.7% |
| alltime | all time | -75.8% | +240.3% | -81.8% | +304.7% |
Monte Rosa Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 6.03(-8.1%) |
| Jun 2024 | - | 6.56(+36.1%) |
| Mar 2024 | - | 4.82(-4.9%) |
| Dec 2023 | 5.07(-53.0%) | 5.07(-37.3%) |
| Sep 2023 | - | 8.09(-25.8%) |
| Jun 2023 | - | 10.90(-7.1%) |
| Mar 2023 | - | 11.73(+8.7%) |
| Dec 2022 | 10.79 | 10.79(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 13.55(-32.6%) |
| Jun 2022 | - | 20.11(-21.6%) |
| Mar 2022 | - | 25.65(+22.4%) |
| Dec 2021 | 20.96(+1306.7%) | 20.96(-27.9%) |
| Sep 2021 | - | 29.08(-12.4%) |
| Jun 2021 | - | 33.20(+75.8%) |
| Mar 2021 | - | 18.89(+1167.8%) |
| Dec 2020 | 1.49(-34.4%) | 1.49 |
| Dec 2019 | 2.27 | - |
FAQ
- What is Monte Rosa Therapeutics annual current ratio?
- What is the all time high annual current ratio for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual current ratio year-on-year change?
- What is Monte Rosa Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly current ratio year-on-year change?
What is Monte Rosa Therapeutics annual current ratio?
The current annual current ratio of GLUE is 5.07
What is the all time high annual current ratio for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual current ratio is 20.96
What is Monte Rosa Therapeutics annual current ratio year-on-year change?
Over the past year, GLUE annual current ratio has changed by -5.72 (-53.01%)
What is Monte Rosa Therapeutics quarterly current ratio?
The current quarterly current ratio of GLUE is 6.03
What is the all time high quarterly current ratio for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly current ratio is 33.20
What is Monte Rosa Therapeutics quarterly current ratio year-on-year change?
Over the past year, GLUE quarterly current ratio has changed by 0.00 (0.00%)